LDX
CEO just confirmed they are replacing the reader for Hologics primary sales product in FFN.
My post yesterday.
Further reading into Hologic and the products available, I have a feeling Lumos is upgrading a new assay ready for Hologic to either replace or improve an existing assay reader:
The above is the Hologic TLiIQ® Rapid fFN diagnostic assay reader.
What is it designed to do? fFN is an adhesive glycoprotein found at the maternal-fetal interface which functions like a glue to bind the baby to the uterus during fetal development.1fFN is generally absent in vaginal secretions during weeks 16 to 35 of gestation, so if fetal fibronectin is detectable in vaginal discharge during pregnancy weeks 22-35, it means that the protein is “leaking.” This can alert healthcare providers that the patient is at risk of preterm birth.Just confirmed by the CEO as being replaced with LDX reader platform.
- Forums
- ASX - Day Trading
- Morning Trading January 16
Morning Trading January 16, page-120
-
-
- There are more pages in this discussion • 131 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online